Terms: = Germ cell tumor AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
28 results:
1. [Dynamic trajectory and cell communication of different cell clusters in malignant progression of glioblastoma].
Cai X; Wang R; Wang S; Ren Z; Yu Q; Li D
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):199-206. PubMed ID: 38595234
[TBL] [Abstract] [Full Text] [Related]
2. The evaluation of six genes combined value in glioma diagnosis and prognosis.
Lin P; He L; Tian N; Qi X
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12413-12433. PubMed ID: 37439825
[TBL] [Abstract] [Full Text] [Related]
3. Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis.
Molinelli E; Ceccarelli G; Fantone S; Di Mercurio E; Gambini D; Maurizi A; Perugini J; Tossetta G; Brisigotti V; De Simoni E; Sapigni C; Rizzetto G; Campanati A; Simonetti O; Marzioni D; Offidani A
Pigment Cell Melanoma Res; 2023 Sep; 36(5):423-430. PubMed ID: 37334675
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients.
Zhong Q; Zhong Q; Cai X; Wu R
Genes Genomics; 2023 Sep; 45(9):1211-1226. PubMed ID: 37301776
[TBL] [Abstract] [Full Text] [Related]
5. Exosomal Plasminogen Activator Inhibitor-1 Induces Ionizing Radiation-Adaptive Glioblastoma Cachexia.
Shin E; Kang H; Lee H; Lee S; Jeon J; Seong K; Youn H; Youn B
Cells; 2022 Oct; 11(19):. PubMed ID: 36231065
[TBL] [Abstract] [Full Text] [Related]
6. Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas.
Ji H; Liu Z; Wang N; Jin J; Zhang J; Dong J; Wang F; Yan X; Gong Q; Zhao H; Sun H; Li Y; Hu S; You C
Front Immunol; 2022; 13():970702. PubMed ID: 36159811
[TBL] [Abstract] [Full Text] [Related]
7. Identification of a novel circular RNA circZNF652/miR-486-5p/serpine1 signaling cascade that regulates cancer aggressiveness in glioblastoma (GBM).
Liu L; Xiao S; Wang Y; Zhu Z; Cao Y; Yang S; Mai R; Zheng Y
Bioengineered; 2022 Jan; 13(1):1411-1423. PubMed ID: 35258403
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Autophagy-Related Prognostic Signature and Analysis of Immune cell Infiltration in Low-Grade Gliomas.
Quan Q; Xiong X; Wu S; Yu M
Biomed Res Int; 2021; 2021():7918693. PubMed ID: 34790823
[TBL] [Abstract] [Full Text] [Related]
9. Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs.
Georgescu MM; Islam MZ; Li Y; Traylor J; Nanda A
Acta Neuropathol Commun; 2021 Apr; 9(1):69. PubMed ID: 33853673
[TBL] [Abstract] [Full Text] [Related]
10. Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics.
Chen B; Ding P; Hua Z; Qin X; Li Z
Invest New Drugs; 2021 Feb; 39(1):52-65. PubMed ID: 32772341
[TBL] [Abstract] [Full Text] [Related]
11. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
[TBL] [Abstract] [Full Text] [Related]
12. NAMPT, GRN, and serpine1 signature as predictor of disease progression and survival in gliomas.
Vachher M; Arora K; Burman A; Kumar B
J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
[TBL] [Abstract] [Full Text] [Related]
13. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract] [Full Text] [Related]
14. Downregulation of PRMT1 promotes the senescence and migration of a non-MYCN amplified neuroblastoma SK-N-SH cells.
Lee YJ; Chang WW; Chang CP; Liu TY; Chuang CY; Qian K; Zheng YG; Li C
Sci Rep; 2019 Feb; 9(1):1771. PubMed ID: 30741995
[TBL] [Abstract] [Full Text] [Related]
15. tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis.
Schroder WA; Major LD; Le TT; Gardner J; Sweet MJ; Janciauskiene S; Suhrbier A
Cancer Med; 2014 Jun; 3(3):500-13. PubMed ID: 24644264
[TBL] [Abstract] [Full Text] [Related]
16. serpine1 expression discriminates site-specific metastasis in human melanoma.
Klein RM; Bernstein D; Higgins SP; Higgins CE; Higgins PJ
Exp Dermatol; 2012 Jul; 21(7):551-4. PubMed ID: 22716255
[TBL] [Abstract] [Full Text] [Related]
17. Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas.
Ulisse S; Baldini E; Mottolese M; Sentinelli S; Gargiulo P; Valentina B; Sorrenti S; Di Benedetto A; De Antoni E; D'Armiento M
BMC Cancer; 2010 Apr; 10():151. PubMed ID: 20403162
[TBL] [Abstract] [Full Text] [Related]
18. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract] [Full Text] [Related]
19. A personalized approach to cancer treatment: how biomarkers can help.
Duffy MJ; Crown J
Clin Chem; 2008 Nov; 54(11):1770-9. PubMed ID: 18801934
[TBL] [Abstract] [Full Text] [Related]
20. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
[TBL] [Abstract] [Full Text] [Related]
[Next]
